Payments to Medical Institutions, Healthcare Professionals, etc.

Chugai discloses information in accordance with Transparency Guidelines for Chugai Activities Involving Medical Institutions, etc., to ensure the transparency of its activities with medical institutions and thereby demonstrate to the wider community that its corporate activities are based on high ethical and moral standards.
Funding provided to Japanese medical institutions and healthcare professionals for each fiscal year (January 1 to December 31) is disclosed in the following five categories:A. Research and development expenses, etc., B. Academic research support expenses, C. Manuscript/writing fees, etc., D. Information provision-related expenses, and E. other expenses.

Fiscal Year 2020

A. Research and development expenses, etc.

Research and development expenses, etc. include expenses required for research/surveillance, etc. conducted under public regulations and various policies such as the Clinical Trials Act and GCP/GVP/GPSP ordinances under the Pharmaceutical and Medical Device Act. Funds, etc. provided shall be disclosed as follows together with the annual total amount of each item.

Category Total annual transfer of value
Expenses for specified clinical traials 295,004,550
Research expenses based on ethical guidelines 637,467,710
drug 90.4g
Non-clinical research expenses 1,833,312,376
drug 2607.8g
active ingredients/reagent 6867.99mg
Clinical trial expenses 5,562,778,010
Post-marketing clinical study expenses 159,056,596
Adverse drug reaction and infection case reporting expenses 7,718,042
Post-marketing surveillance expenses 63,939,290
Other expenses 887,625,954

B. Academic research support expenses

Scholarship donations and general donations for promotion of academic research or research support, etc., and donations to academic societies, etc. and expenses of co-sponsored conferences, etc., as expenses to academic societies, etc. for supporting conferences. Funds, etc. provided shall be disclosed as follows together with the annual total amount of each item.

Category Number of donations Total for fiscal year
Scholarship donations 1,555 1,350,500,000
General donations 86 504,588,000
Donations to academic societies - 87,582,050
Academic society co-hosting expenses - 317,936,976

C. Manuscript/writing fees, etc.

Fees, etc. for provision of scientific information, etc. on the company’s pharmaceutical products, medicine, and pharmacy or fees, etc. paid as consideration for lectures and writing or supervision of the manuscript that are related to research and development, or commissioning of services including consulting contracts, etc. Funds, etc. provided shall be disclosed as follows together with the annual total amount of each item.

Category Number of payments for fiscal year Total for fiscal year
Lecturer honoraria 5,485 415,571,226
Manuscript writing and editorial supervision fees 543 38,969,378
Other outsourcing expenses 2,497 221,538,195

D. Information provision-related expenses

Expenses of lecture meetings and explanation meetings, etc. for providing information, etc. related to the company’s pharmaceutical products, medicine and pharmacy to medical professionals.

Category Number of payments for fiscal year Total for fiscal year
Expenses for lecture meetings and other meetings 5,589 1,420,127,367
Briefing expenses 8,370 180,231,362
Expenses for providing medical and pharmaceutical literature and other goods - 161,101,599

E. Other expenses

Expenses for hospitality, etc. as social courtesy

Category Total for fiscal year
Hospitality expenses 15,966,996
  • Like
  • Tweet
  • LINE it!
  • E-mail

Chugai's Transparency Guidelines

Back to top